Infectious disease: New HIV-1 prodrug shows promise in phase III trials.
Louise
L
Stone
D000225:Adenine / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002219:Carbamates / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage*; D015363:Quinolones / Q000008:administration & dosage*; D013844:Thiazoles / Q000008:administration & dosage*
D019380:Anti-HIV Agents; D002219:Carbamates; D063065:Organophosphonates; D015363:Quinolones; D013844:Thiazoles; D003841:Deoxycytidine; D000225:Adenine